Amino acid replacement: H334L.
A22286987T
H334L | Hem-PA
H334L
Site of nucleic acid difference in mutant inferred by FlyBase based on reported amino acid change.
Unfused myoblasts are apparent in HemG1-37 mutant embryos until stage 15. By stage 16 hardly any unfused myoblasts are present, but there are large gaps in the muscle pattern and epidermal-muscle attachments are frequently missing or incorrect. Dorsal closure is normal in these embryos, as is formation of the dorsal vessel and cardioblasts.
HemG1-37 has larval somatic muscle cell phenotype, enhanceable by blow[+]/blow2
HemG1-37 has somatic muscle primordium phenotype, enhanceable by blow[+]/blow2
HemG1-37 is a non-enhancer of larval somatic muscle cell phenotype of blow2
HemG1-37 is a non-enhancer of somatic muscle primordium phenotype of blow2
Allelic series based on mutant phenotype; HemC3-20 = HemJ4-48 > HemP168 > HemG1-37 > HemJ1-70.